SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001599298-22-000084
Filing Date
2022-07-26
Accepted
2022-07-26 16:31:17
Documents
15
Period of Report
2022-07-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K smmt-20220725.htm   iXBRL 8-K 42504
2 EX-99.1 a2022_prx0726xappointmento.htm EX-99.1 15472
7 image_0a.jpg GRAPHIC 36776
  Complete submission text file 0001599298-22-000084.txt   282291

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20220725.xsd EX-101.SCH 2159
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20220725_def.xml EX-101.DEF 14830
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20220725_lab.xml EX-101.LAB 28736
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20220725_pre.xml EX-101.PRE 15427
9 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20220725_htm.xml XML 11091
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36866 | Film No.: 221107464
SIC: 2834 Pharmaceutical Preparations